MaxCyte, Inc. (MXCT) Net margin 2019–2025
MaxCyte, Inc. (MXCT) net profit margin by fiscal year — reported net income divided by reported revenue.
-213.0%FY2025 · since FY2019: -97.3% → -213.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -213.0% | -28.2 pp |
| FY2024 | -184.8% | +9.7 pp |
| FY2023 | -194.5% | -112.5 pp |
| FY2022 | -82.0% | +6.5 pp |
| FY2021 | -88.5% | -12.0 pp |
| FY2020 | -76.5% | +20.8 pp |
| FY2019 | -97.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice